Our Opinion

Celularity Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Previously, Celularity has developed a specific animal model that allows for the evaluation of safety, biodistribution, persistence, and maturation of PNK-007 in vivo.” Read the full document

Company Description

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.

Company Website: https://celularity.com